期刊文献+

前列腺干细胞抗原在人前列腺癌组织中的表达及意义 被引量:2

Expression of prostate stem cell antigen in human prostate cancer and its significance
原文传递
导出
摘要 目的 探讨前列腺干细胞抗原 (PSCA)在国人前列腺癌 (PCa)组织中表达的临床意义。 方法 采用免疫组织化学 (IHC)和核酸原位杂交 (ISH)方法检测 4 0例PCa、2 0例良性前列腺增生(BPH)和 2 0例前列腺上皮内瘤 (PIN)组织标本PSCA蛋白和mRNA表达 ,半定量法计算PSCA阳性表达细胞百分数和阳性表达强度 ,比较各组织间表达水平的差异及其与PCa分级、临床分期之间的关系。 结果 PCa、BPH、PIN组织PSCA中度阳性到强阳性表达分别为 85 % (34/ 4 0 )、2 0 % (4/ 2 0 )和35 % (7/ 2 0 ) ;PCa组织PSCA表达水平与BPH和PIN比较差异有统计学意义 (P <0 .0 5 ) ,BPH与PIN比较差异无统计学意义 (P >0 .0 5 ) ;PCa组织PSCA表达水平随Gleason评分及临床分期增加而升高。 结论 人PCa组织有PSCA蛋白质和mRNA的过表达 ,且与PCa病理分级、临床分期呈正相关 ,可能对PCa的诊断及判断预后有潜在价值。 Objective To investigate the expression of prostate stem cell antigen(PSCA) in human prostate cancer (PCa) specimens and its possible correlations with pathological grade and clinical stage of PCa. Methods Immunohistochemical (IHC) and in situ hybridization (ISH) analyses of PSCA expression were simultaneously performed on paraffin-embedded sections from 20 cases of benign prostatic hyperplasia (BPH),20 cases of prostatic intraepithelial neoplasm (PIN) and 40 cases of (PCa) tissues.The levels of PSCA protein mRNA expression were semiquantitatively scored by assessing both the percentage and intensity of PSCA-positive staining cells in the specimens,and then were compared among PCa,BPH and PIN tissues. Results The moderate to strong positive rate of expression of PSCA protein and mRNA in PCa,BPH and PIN tissue was 85%,20% and 35%,respectively.Significant difference of expression was found between PCa and BPH,PIN samples (P<0.05).No significant difference of expression was found between BPH and PIN samples (P>0.05).The expression level of PSCA increased with higher Gleason score and worsening clinical stage (P<0.05 for both). Conclusions The results demonstrate that PSCA as a new cell surface marker is overexpressed in a majority of human PCa tissues.PSCA expression correlates positively with pathological grade and clinical stage of PCa.PSCA may have potential value for the diagnosis and prediction of prognosis of PCa.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2004年第12期807-809,共3页 Chinese Journal of Urology
关键词 前列腺干细胞抗原 前列腺癌 癌组织 表达 Prostatic neoplasms Carcinoma Prostate stem cell antigen
  • 相关文献

参考文献6

  • 1Dubey P, Wu H, Reiter RE, et al. Alternative pathways to prostate carcinoma activate prostate stem cell antigen expression. Cancer Res,2001,61:3256-3261.
  • 2Visa korpi T, Kallioniemi AH, Syvanen AC, et al. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res, 1995,55:342-347.
  • 3Sato K, Qian J, Slezak JM, et al. Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma. J Natl Cancer Inst, 1999,91:1574-1580.
  • 4Van Den Berg C,Guan XY,Von Hoff D,et al. DNA sequence amplification in human prostate cancer identified by chromosome microdissection:potential prognostic implications. Clin Cancer Res, 1995,1:11-18.
  • 5Reiter RE,Sato I,Thomas G,et al. Coamplification of prostate stem cell antigen ( PSCA ) and MYC in locally advanced prostate cancer.Genes Chromosomes Cancer,2000,27:95-103.
  • 6Gu Z, Thomas G, Yamashiro J, et al. Prostate stem cell antigen (PSCA) expression increases with high Gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene, 2000, 19:1288-1296.

共引文献1

同被引文献17

  • 1杨轶凡,孔祥波,谷欣权,王春喜.前列腺干细胞抗原在人前列腺癌组织中的表达及意义[J].中国老年学杂志,2006,26(7):886-888. 被引量:11
  • 2[1]Dannull J,Dieener PA,Prikler L,et al.Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer[J].Cancer Res,2000,60(19):5522-5528
  • 3[4]Thomas G,Yamashino J,Shintaku IP,et al.Prostate stem cell antigen (PSCA) expression increases with high gleason score,advanced stage and bone metastasis in prostate cancer[J].Oncogene,2000,19(10):1288-1296
  • 4[5]Han KR,Seligson DB,Liu X,et al.Prostate stem cell antigen expression is associated with gleason score,seminal vesicle invasion and capsular invasion in prostate cancer[J].Jurol,2004,171(3):1117-1121
  • 5[7]Fleming ID,Cooper JS,Henson DE,et al.American Joint Committee on Cancer,Manual for Staging of Cancer,5th ed[M].Lippincott Philadelphia,1997:220
  • 6[8]Reiter RE,Gu Z,Watabe T,Thomas G,et al.Prostate stem cell antigen a cell surface marker overexpressed in prostate cancer[J].Proc Natl Acad Sei USA,1998,95(4):1735-1740
  • 7Ahmedin J,Rebecca S,Elizabeth W,et al.Cancer Statistics[J].C A Cancer J Clin,2006,56:106-130.
  • 8Parkin DM,Bray F,Ferlay J,et al.Global Cancer Statistics[J].CA Cancer J Clin,2005,55:74-108.
  • 9Lalaniel N,Laniado ME,Abel PD.Molecular and cellular biology of prostate cancer[J].Cancer Metastasis Rev,1997,16:29-66.
  • 10Crawford ED,Deantronl EP.PSA as a screening test for prostate cancer[J].Urol clin Nort Am,1993,20:637-650.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部